Targeted deletion of Rad9 in mouse skin keratinocytes enhances genotoxin-induced tumor development.
Targeted deletion of Rad9 in mouse skin keratinocytes enhances genotoxin-induced tumor development.
复制标题
DOI:
10.1158/0008-5472.can-07-5670
复制
发表时间:
2008-07-15
期刊:
影响因子:
11.2
通讯作者:
Hang H
中科院分区:
文献类型:
--
作者:
Hu Z;Liu Y;Zhang C;Zhao Y;He W;Han L;Yang L;Hopkins KM;Yang X;Lieberman HB;Hang H
The Rad9 gene is evolutionarily conserved from yeast to human, and plays crucial roles in genomic maintenance, DNA repair and cell cycle checkpoint controls. However, the function of this gene with respect to tumorigenesis is not well understood. A Rad9-null mutation in mice causes embryonic lethality. In this study, we created mice in which mouse Rad9, Mrad9, was deleted only in keratinocytes to permit examination of the potential function of the gene in tumor development. Mice with Mrad9+/− or Mrad9−/− keratinocytes demonstrated no overt, spontaneous morphological defects and appeared similar to wild-type controls. Painting the carcinogen 7,12-dimethylbenzanthracene (DMBA) onto the skin of the animals caused earlier onset and more frequent formation of tumors and senile skin plaques in Mrad9−/− mice, compared to Mrad9+/− and Mrad9+/+ littermates. DNA damage response genes p21, p53 and Mrad9B were expressed at higher levels in Mrad9−/− relative to Mrad9+/+ skin. Keratinocytes isolated from Mrad9−/− skin had more spontaneous and DMBA-induced DNA double strand breaks than Mrad9+/+ keratinocytes, and the levels were reduced by incubation with the antioxidant EGCG. These data suggest that Mrad9 plays an important role in maintaining genomic stability and preventing tumor development in keratinocytes.